14.88

0.21% 0.0307

After Hours: 14.88 -0.0007 -0.00%

Telix Pharmaceuticals Ltd Adr (TLX)

Overview News Price History Discussions Forecast

Telix Pharmaceuticals Ltd Adr stock is traded at $14.88, with a volume of 20,131. It is up +0.21% in the last 24 hours and up +0.00% over the past month. Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Previous Close:

$14.85

Open:

$15.4211

24h Volume:

20,131

Relative Volume:

22.04

Market Cap:

$N/A

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+0.00%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$14.75

$15.89

1-Week Range:

$14.75

$15.90

52-Week Range:

$14.75

$15.90

Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile

Name

Telix Pharmaceuticals Ltd Adr

Sector

Healthcare (1196)

Industry

Biotechnology (683)

Phone

Address

Employee

234

Twitter

Next Earnings Date

Latest SEC Filings

TLX's Discussions on Twitter

Compare TLX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLX	14.88	0	0	0	0	0.00
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54